Drug · DIN 02554003
VABYSMO
PREFILLED SYRINGE
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since June 30, 2025; first marketed June 30, 2025.
- Drug Identification Number (DIN)
- 02554003
- Company (DIN owner)
- Hoffmann-La Roche LimitedMississauga, Ontario, Canada
- Schedule
- Prescription; Schedule D
- Dosage form
- Solution
- Route
- Intravitreal
- Therapeutic class (ATC)
- Faricimab S01LA09
- Class
- Human
- Record last updated
- August 20, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| FARICIMAB | 6 MG | 0.05 ML |
Notices of Compliance
Health Canada approvals that name this DIN.
- December 13, 2024: NOC 34559Supplement to a New Drug Submission (SNDS) · Addition of new presentation
Other DINs named VABYSMO
- DIN 02527618 · Marketed